A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis

American Journal of Gastroenterology

Volumn 95, Issue 5, 2000, Pages 1263-1276

  Cohen, Russell D ^d   Woseth, Douglas M ^a,b   Thisted, Ronald A ^c   Hanauer, Stephen B ^a  

^a Surg Elec Comp Eng Univ I   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Chicago Department of Health   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; BECLOMETASONE DIPROPIONATE; BETAMETHASONE; BUDESONIDE; CORTICOSTEROID; ENEMA; FLUTICASONE PROPIONATE; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; MESALAZINE; OLSALAZINE; PREDNISOLONE; PREDNISOLONE 3 SULFOBENZOATE; SALAZOSULFAPYRIDINE; TIXOCORTOL PIVALATE;

ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG WITHDRAWAL; FOAM; HUMAN; MEDICAL LITERATURE; META ANALYSIS; PRIORITY JOURNAL; PROCTITIS; RECTUM ULCER; REMISSION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; GLUCOCORTICOIDS; HUMANS; MESALAMINE; PROCTITIS; REMISSION INDUCTION;

EID: 0034061366     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00732-2     Document Type: Article

References (94)

1. Schulz K.F., Chalmers I., Hayes R.J., et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 273:1995;408-412.
2. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 7:1986;177-188.
3. Campieri M., Gionchetti P., Belluzzi A., et al. Sucralfate, 5-aminosalicylic acid, and placebo enemas in the treatment of distal ulcerative colitis. Eur J Gastroenterol Hepatol. 3:1991;41-44.
4. Campieri M., Gionchetti P., Belluzzi A., et al. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Gut. 32:1991;929-931.
5. Watkinson G. Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium A controlled trial employing restricted sequential analysis. Br Med J 1958:1077-82.
6. Angus P., Snook J.A., Reid M., et al. Oral fluticasone propionate in active distal ulcerative colitis. Gut. 33:1992;711-714.
7. Sutherland L.R., Martin F., Greer S., et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 92:1987;1894-1898.
8. Fruhmorgen P., Demling L. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon. Hepatogastroenterology. 27:1980;473-476.
9. Ginsberg A.L., Beck L.S., McIntosh T.M., et al. Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial. Ann Intern Med. 108:1988;195-199.
10. Danielsson A., Lofberg R., Persson T., et al. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scand J Gastroenterol. 27:1992;9-12.
11. Hanauer S., Schwartz J., Robinson M., et al. Mesalamine capsules for treatment of active ulcerative colitis Results of a controlled trial. Pentasa Study Group . Am J Gastroenterol. 88:1993;1188-1197.
12. Selby W.S., Barr G.D., Ireland A., et al. Olsalazine in active ulcerative colitis. Br Med J (Clin Res Ed). 291:1985;1373-1375.
13. Farella S., Mandrioli M., Marzo C. 5 ASA enemas in ulcerative colitis on the onset 22 cases . Lit Rev Ther Inflam Bowel Dis. 28:1991;425.
14. McPhee M.S., Swan J.T., Biddle W.L., et al. Proctocolitis unresponsive to conventional therapy. Response to 5- aminosalicylic acid enemas. Dig Dis Sci. 32:1987;76S-81S.
15. LaRosa D., Rubin P.H., Bodian C., et al. Maintenance oral sulfasalazine prolongs remission in ulcerative proctitis and proctosigmoiditis. Am J Gastroenterol. 86:1991;1456-1460.
16. Biddle W.L., Miner P.B. Jr. Long-term use of mesalamine enemas to induce remission in ulcerative colitis. Gastroenterology. 99:1990;113-118.
17. Porro G.B., Prantera C., Campieri M., et al. Comparative trial of methylprednisolone and budesonide enemas in active distal ulcerative colitis. Eur J Gastroenterol Hepatol. 6:1994;125-130.
18. Sharma M.P., Duphare H.V., Dasarathy S. A prospective randomized double blind trial comparing prednisolone and 4-aminosalicylic acid enemas in acute distal ulcerative colitis. J Gastroenterol Hepatol. 7:1992;173-177.
19. Riley S.A., Gupta I., Mani V. A comparison of sucralfate and prednisolone enemas in the treatment of active distal ulcerative colitis. Scand J Gastroenterol. 24:1989;1014-1018.
20. Lofberg R., Ostergaard Thomsen O., Langholz E., et al. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. (published erratum appears in Aliment Pharmacol Ther 1995 Apr;9(2):213) Aliment Pharmacol Ther. 8:1994;623-629.
21. van der Heide H., van den Brandt-Gradel V., Tytgat G.N., et al. Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis. J Clin Gastroenterol. 10:1988;169-172.
22. O'Donnell L.J., Arvind A.S., Hoang P., et al. Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis. Gut. 33:1992;947-949.
23. Hanauer S., Robinson M. Dose ranging study of budesonide enema in active distal ulcerative colitis. Gastroenterology. 108:1995;A832.
24. Marteau P., Halphen M. Comparative randomized open study of the efficacy, and tolerance of enemas with 2 gr of 4-amino-salicylic acid (4-ASA), and 1 gr of 5-amino-salicylic acid (5-ASA) in distal forms of hemorrhagic rectocolitis. Gastroenterol Clin Biol. 19:1995;31-35.
25. Powell-Tuck J., Parkins R.A. Controlled comparison of enemas containing 1g and 2g 5 aminosalicylic acid in patients with ulcerative proctosigmoiditis. Gut. 25:1984;A1143.
26. Basilisco G., Ranzi T., Campanini M., et al. 5-aminosalicylic acid or sulfasalazine retention enemas in distal ulcerative colitis. A randomized therapeutic trial. Curr Therapeut Res. 42:1987;910-915.
27. Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis. A randomized, double-blind multicenter trial. Dig Dis Sci. 32:1987;598-602.
28. Campieri M., Paoluzi P., D'Albasio G., et al. Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema. Dig Dis Sci. 38:1993;1843-1850.
29. Farup P.G., Hovde O., Halvorsen F.A., et al. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol. 30:1995;164-170.
30. Borkje B., Riedel B., Berstad A. Jr, et al. Effect of mesalazine (MESASAL) suppositories in patients with ulcerative proctitis or proctosigmoiditis. Scand J Gastroenterol. 28:1993;A49.
31. Guarino J., Chatzinoff M., Berk T., et al. 5-aminosalicylic acid enemas in refractory distal ulcerative colitis Long-term results . Am J Gastroenterol. 82:1987;732-737.
32. Kandel G., Prokipchuk E.J. 5-ASA enemas for refractory distal ulcerative colitis. An open trial. J Clin Gastroenterol. 9:1987;536-540.
33. Friedman L.S., Richter J.M., Kirkham S.E., et al. 5-aminosalicylic acid enemas in refractory distal ulcerative colitis. A randomized, controlled trial. Am J Gastroenterol. 81:1986;412-418.
34. Habal F.M., Greenberg G.R. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Am J Gastroenterol. 83:1988;15-19.
35. Triantafillidis J.K., Nicolakis D., Dadioti P., et al. High doses of 5-aminosalicylic acid (5-ASA) enemas in moderate left-sided ulcerative colitis (UC). Comparison with betamethasone (BE), enemas. Lit Rev Ther Inflam Bowel Dis. 32:1992;649.
36. Hanauer S.B., Kirsner J.B., Barrett W.E. The treatment of left sided ulcerative colitis with tixocortol pivalate (TP). Gastroenterology. 90:1986;1449.
37. Jones J.H., Lennard-Jones J.E., Misiewicz J.J., et al. Betamethasone 17-valerate, and prednisolone 21-phosphate retention enemata in proctocolitis. A multicentre trial. Br Med J. 3:1971;84-86.
38. Bansky G., Buhler H., Stamm B., et al. Treatment of distal ulcerative colitis with beclomethasone enemas High therapeutic efficacy without endocrine side effects. A prospective, randomized, double-blind trial . Dis Colon Rectum. 30:1987;288-292.
39. Lemann M., Galian A., Rutgeerts P., et al. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Aliment Pharmacol Ther. 9:1995;557-562.
40. Pullan R.D., Ganesh S., Mani V., et al. Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis A controlled trial . Gut. 34:1993;676-679.
41. Massa P., Michetti P., Dodero M. 5-ASA suppositories in topical treatment of ulcerative colitis (UC). Gastroenterology. 98:1990;A189.
42. Lee F.I., Jewell D.P., Mani V., et al. A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. Gut. 38:1996;229-233.
43. Porro G.B., Ardizzone S., Petrillo M., et al. Low pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis A randomized, double-blind study . Am J Gastroenterol. 90:1995;736-739.
44. Campieri M., Lanfranchi G.A., Bertoni F., et al. A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis. Digestion. 29:1984;204-208.
45. Halpern Z., Sold O., Baratz M., et al. A controlled trial of beclomethasone versus betamethasone enemas in distal ulcerative colitis. J Clin Gastroenterol. 13:1991;38-41.
46. Rao S.S., Dundas S.A., Holdsworth C.D., et al. Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study. Gut. 30:1989;675-679.
47. Sutherland L.R., Martin F. 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada. Dig Dis Sci. 32:1987;64S-66S.
48. Selby W.S., Bennett M.K., Jewell D.P. Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas. Digestion. 29:1984;231-234.
49. Campieri M., Lanfranchi G.A., Brignola C., et al. High-dose 5-aminosalicylic acid enemas in the treatment of ulcerative colitis. Intern Med Special. 5:1984;164-171.
50. Janssens J., Geboes K., Delanote C., et al. 5-Amino-salicylic acid (5-ASA) enemas are effective in patients with resistent ulcerative rectosigmoiditis. Gastroenterology. 84:1983;1198.
51. Safdi M., DeMicco M., Sninsky C., et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol. 92:1997;1867-1871.
52. Ruddell W.S., Dickinson R.J., Dixon M.F., et al. Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse Comparison of hydrocortisone enemas and rectal hydrocortisone foam . Gut. 21:1980;885-889.
53. Hamilton I., Pinder I.F., Dickinson R.J., et al. A comparison of prednisolone enemas with low-dose oral prednisolone in the treatment of acute distal ulcerative colitis. Dis Colon Rectum. 27:1984;701-702.
54. Hetzel D.J., Shearman D.J., Labrooy J., et al. Olsalazine in the treatment of active ulcerative colitis A placebo controlled clinical trial and assessment of drug disposition . Scand J Gastroenterol. 148:(suppl):1988;61-69.
55. Ewe K., Eckardt V., Kanzler G. Treatment of ulcerative colitis with olsalazine and sulphasalazine Efficacy and side-effects . Scand J Gastroenterol. 148:(suppl):1988;70-75.
56. Friedman G. Treatment of refractory proctosigmoiditis and left-sided colitis with a rectally-instilled non-glucocorticoid, non-mineralocorticoid steroid. Gastroenterology. 88:1985;1388.
57. Ginsberg A.L., Steinberg W.M., Nochomovitz L.E. Evaluation of 4-amino salicylate enemas in patients with left-sided ulcerative colitis. Gastroenterology. 86:1984;A1089.
58. Kam L., Cohen H., Dooley C., et al. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults. Am J Gastroenterol. 91:1996;1338-1342.
59. Miner P., Hanauer S., Robinson M., et al. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. Dig Dis Sci. 40:1995;296-304.
60. Andreoli A., Spinella S., Levenstein S., et al. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Ital J Gastroenterol. 26:1994;365.
61. Travis S.P., Tysk C., de Silva H.J., et al. Optimum dose of olsalazine for maintaining remission in ulcerative colitis. Gut. 35:1994;1282-1286.
62. Sutherland L., Martin F. 5-Aminosalicylic acid enemas in the maintenance of remission in distal ulcerative colitis and proctitis. Can J Gastroenterol. 1:1987;3-6.
63. Campieri M., Gionchetti P., Belluzzi A., et al. 5-Aminosalicylic acid suppositories in the management of ulcerative colitis. Dis Colon Rectum. 32:1989;398-399.
64. Sandberg-Gertzen H., Jarnerot G., Kraaz W. Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties. Gastroenterology. 90:1986;1024-1030.
65. D'Arienzo A., Panarese A., D'Armiento F.P., et al. 5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis. A double-blind placebo- controlled clinical trial. Am J Gastroenterol. 85:1990;1079-1082.
66. Miner P., Daly R., Nester T., et al. The effect of varying dose intervals of mesalamine enemas for the prevention of relapse in distal ulcerative colitis. Gastroenterology. 106:1994;A736.
67. D'Albasio G., Trallori G., Bardazzi G., et al. Comparison of intermittent versus continuous sulphasalazine treatment for maintaining remission in ulcerative colitis. Lit Rev Ther Inflam Bowel Dis. 32:1992;642.
68. Campieri M., De Franchis R., Bianchi Porro G., et al. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial. Scand J Gastroenterol. 25:1990;663-668.
69. Ngo Y., Gelinet J.M., Ivanovic A., et al. Efficacy of a daily application of mesalazine (Pentasa) suppository with progressive release, in the treatment of ulcerative proctitis. A double-blind versus placebo randomized trial. Gastroenterol Clin Biol. 16:1992;782-786.
70. Campieri M., Gionchetti P., Belluzzi A., et al. Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial. Int J Colorectal Dis. 5:1990;79-81.
71. Williams C.N., Haber G., Aquino J.A. Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using 99mTc- labeled 5-ASA suppositories. Dig Dis Sci. 32:1987;71S-75S.
72. Williams C.N. Efficacy and tolerance of 5-aminosalicylic acid suppositories in the treatment of ulcerative proctitis A review of two double-blind, placebo controlled trials . Can J Gastroenterol. 4:1990;472-475.
73. Kohn A., Luzi C., Iurato S., et al. 5-ASA suppositories. A double blind trial in ulcerative proctitis. Lit Rev Ther Inflam Bowel Dis. 32:1992;173.
74. Lennard-Jones J.E., Baron J.H., Connell A.M., et al. A double blind controlled trial of prednisolone-21-phosphate suppositories in the treatment of idiopathic proctitis. Gut. 3:1962;207-210.
75. Trallori G., Messori A., Scuffi C., et al. 5-Aminosalicylic acid enemas to maintain remission in left-sided ulcerative colitis. A meta- and economic analysis. J Clin Gastroenterol. 20:1995;257-259.
76. Campieri M., Gionchetti P., Belluzzi A., et al. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? J Clin Gastroenterol. 10:1988;406-409.
77. Bertone A, Spandre M, Gemme C, et al. 13 5-ASA suppositories in topical treatment of ulcerative colitis. Eur J Gastroenterol Hepatol 1990;2:407;S408.
78. Moller C., Kiviluoto O., Santavirta S. Local treatment of ulcerative proctitis with salicylazosulpyridine (salazopyrin) enema. Clin Trials J. 15:1978;199-203.
79. Connell A.M., Lennard-Jones J.E., Misiewicz J.J., et al. Comparison of acetarsol and prednisolong-21-phosphate suppositories in the treatment of idiopathic proctitis. Lancet. 1:1965;238-239.
80. Mulder C.J., Endert E., van der Heide H., et al. Comparison of beclomethasone dipropionate (2 and 3 mg) and prednisolone sodium phosphate enemas (30 mg) in the treatment of ulcerative proctitis. An adrenocortical approach. Neth J Med. 35:1989;18-24.
81. Mulder C.J., Tytgat G.N., Wiltink E.H., et al. Comparison of 5-aminosalicylic acid (3 g), and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial. Scand J Gastroenterol. 23:1988;1005-1008.
82. Hanauer S., Borgen L., Reiss L., et al. Maintenance treatment of ulcerative proctitis with mesalmine suppositories Results of a multicenter two-year controlled trial . Gastroenterology. 102:1992;A634.
83. Sutherland L.R., May G.R., Shaffer E.A. Sulfasalazine revisited A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis . (see comments) Ann Intern Med. 118:1993;540-549.
84. Kornbluth A.A., Salomon P., Sacks H.S., et al. Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis. J Clin Gastroenterol. 16:1993;215-218.
85. Marshall J.K., Irvine E.J. Rectal aminosalicylate therapy for distal ulcerative colitis A meta-analysis . Aliment Pharmacol Ther. 9:1995;293-300.
86. Peto R. Why do we need systematic overviews of randomized trials? Stat Med. 6:1987;233-244.
87. Irvine E. Assessing outcome in randomized clinical trials Inflammatory bowel disease . Can J Gastroenterology. 7:1993;561-567.
88. Chalmers TC. Problems induced by meta-analyses. Stat Med 1991;10:971-9; discussion 979-80.
89. Thompson S.G., Pocock S.J. Can meta-analyses be trusted? (see comments) Lancet. 338:1991;1127-1130.
90. Villar J., Carroli G., Belizan J.M. Predictive ability of meta-analyses of randomised controlled trials. (see comments) Lancet. 345:1995;772-776.
91. Easterbrook P.J., Berlin J.A., Gopalan R., et al. Publication bias in clinical research. (see comments) Lancet. 337:1991;867-872.
92. Messori A., Brignola C., Trallori G., et al. Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease. A meta-analysis. Am J Gastroenterol. 89:1994;692-698.
93. Hay J.W., Hay A.R. Inflammatory bowel disease Costs-of-illness . J Clin Gastroenterol. 14:1992;309-317.
94. Hay A.R., Hay J.W. Inflammatory bowel disease Medical cost algorithms . J Clin Gastroenterol. 14:1992;318-327.